Amniotic fluid C-peptide in normal and insulin-dependent diabetic pregnancies.
Glucose, insulin and C-peptide were determined in amniotic fluid from 28 normal and 46 insulin-treated diabetic pregnant women. Glucose, insulin and C-peptide concentrations in amniotic fluid were higher in the diabetics than in the normal subjects. In diabetic women insulin levels did not correlate with birth weight or birth weight adjusted for gestational age, but C-peptide did. C-peptide correlated poorly with insulin (p < 0.05) in diabetics but closely (p < 0.002) in normal subjects. These results suggest that amniotic fluid investigations in insulin-treated diabetic women should use C-peptide assays as these seem to reflect more closely the insulin production of the fetus than do insulin assays. There were no differences in amniotic fluid glucose, insulin and C-peptide concentrations where the amniotic fluid lecithin-sphingomyelin ratio indicated fetal pulmonary maturity or immaturity.
D000293:Adolescent; D000328:Adult; D000653:Amniotic Fluid / Q000032:analysis*; D002096:C-Peptide / Q000032:analysis*; D005260:Female; D005947:Glucose / Q000032:analysis; D006801:Humans; D007328:Insulin / Q000032:analysis / Q000627:therapeutic use; D007330:Insulin Antibodies / Q000032:analysis; D010455:Peptides / Q000032:analysis*; D010713:Phosphatidylcholines / Q000032:analysis; D011247:Pregnancy; D011254:Pregnancy in Diabetics / Q000188:drug therapy / Q000378:metabolism*; D013109:Sphingomyelins / Q000032:analysis
D002096:C-Peptide; D007328:Insulin; D007330:Insulin Antibodies; D010455:Peptides; D010713:Phosphatidylcholines; D013109:Sphingomyelins; D005947:Glucose